121 results about "Monooxygenase" patented technology

The invention discloses a Vinck Cellulomicrobe and application thereof in degradation of corn straw and improvement of soil fertility, and belongs to the field of agricultural microbial technology and solid waste resource utilization. The bacterial strain can secrete a plurality of hydrolase and oxidase including AA10 family lytic polysaccharide monooxygenase, AA2 peroxidase, GH3 and GH1 beta-glucosidase, GH16 / GH17 beta-glucosan endonuclease and AA1 multi-copper oxidase. The bacterial strain has the advantages that the bacterial strain can secrete a plurality of hydrolase and oxidase; fermentation liquor is applied to soil according to the straw mass ratio of 1: 5, and the corn straw degradation rate can be increased under the condition that the mass ratio of soil to straw is 100: 1. Meanwhile, the microbial agent can synergistically improve soil nutrients and increase the contents of rapidly available phosphorus, rapidly available potassium, alkali-hydrolyzable nitrogen, soluble organic carbon and total phosphorus in soil. According to the microbial agent, a straw lignocellulose structure is effectively cracked through a multi-enzyme system synergistic effect, and the dual effects of accelerating straw degradation and improving soil fertility are achieved.

The invention discloses an alcohol dehydrogenase mutant for high yield of tea flavor ketone and application of the alcohol dehydrogenase mutant in a one-pot method. The mutant is A182L or A182L / V214T. The alcohol dehydrogenase mutant has high catalytic activity on 4-hydroxyisophorone, and the yield of tea flavor ketone prepared by catalysis of the mutant A182L / V214T can reach 97% and is 3.73 times that of an original enzyme; the alcohol dehydrogenase mutant has high catalytic activity of synthesizing the tea aroma ketone through one-pot catalysis of isophorone, and the yield of the tea aroma ketone obtained through direct oxidation of isophorone by jointly using the mutant A182L / V214T and a cytochrome P450BM3 monooxygenase mutant can reach 92%; the alcohol dehydrogenase mutant has the advantages of simple production process, mild reaction conditions and environment-friendly production process, is beneficial to the industrial production of the tea flavor ketone, and has wide application prospects.

The present application relates to a kind of sulfide monooxygenase mutant and its application in esomeprazole synthesis.The sulfide monooxygenase mutant, its encoding gene, the preparation method of the recombinant expression vector containing the gene sequence, co-expression recombinant vector and recombinant expression transformant, and the application of the recombinant sulfide monooxygenase mutant catalyst in esomeprazole synthesis are specifically disclosed.Compared with other sulfide monooxygenases, the sulfide monooxygenase mutant obtained by the present application can efficiently utilize the coenzyme NADH with lower cost and higher stability to catalyze the asymmetric oxidation reaction of omeprazole sulfide, prepare esomeprazole, has the advantages of high substrate concentration, mild reaction condition, environment-friendly, simple operation, high yield, low production cost and good industrial application prospect.

The invention discloses a method and a device for degrading bisphenol A by using a propane matrix membrane bio-membrane reactor, and belongs to the technical field of microorganism application. The method specifically comprises the following steps: inoculating activated sludge into a membrane bio-membrane reactor with a basic inorganic salt culture medium, and introducing propane to promote the growth of a bio-membrane on hollow fiber membrane filaments in the membrane bio-membrane reactor, so as to obtain the membrane bio-membrane reactor after membrane formation is completed; the method comprises the following steps: introducing bisphenol A-containing wastewater to be treated into a membrane bio-membrane reactor, continuously introducing propane, and inducing microorganisms to express alkane monooxygenase and cytochrome P450 monooxygenase, thereby promoting hydroxylation of bisphenol A and degrading bisphenol A into a downstream product of which the toxicity is lower than that of bisphenol A. The propane is used as a carbon source and an electron donor, the propane can be efficiently utilized to provide a safe and good environment for biodegradation of bisphenol A, and secondary pollution possibly caused by a traditional carbon source is avoided.

The invention discloses a genetically engineered bacterium and an application of the genetically engineered bacterium in production of farnesene. The genetically engineered bacterium takes saccharomyces cerevisiae as a chassis strain; an exogenous beta-farnesene synthase gene is integrated, an ERG9 gene is knocked out, a promoter of a truncated HMG1 gene is replaced with an ANB1 promoter, an exogenous transhydrogenase gene is integrated and driven by a glucose sensitive promoter, beta-farnesene synthase is mutated and fused with a transmembrane structural domain of ABC transporter protein PDR10, and then a chimeric expression unit is constructed. According to the present invention, the chassis bacteria are modified by at least one of the steps of overexpression of phosphatidylcholine synthetase, knockout of sterol ester synthetase and introduction of exogenous alkyl glycerol monooxygenase, and the obtained engineering bacteria are combined with the optimized fermentation process so as to significantly improve the farnesene synthesis efficiency and the production economy; therefore, the genetically engineered bacterium and the fermentation method provided by the invention have good application prospects.

The application discloses a kind of generation (4S) 4-hydroxyisophorone monooxygenase mutant and preparation method thereof, the monooxygenase is cytochrome P450 BM3 Monooxygenase from bacillus megaterium. The cytochrome P450 BM3 Monooxygenase mutant has high stereoselectivity and high reaction activity to catalyze isophorone hydroxylation, mutant R47L / Y51F / F81W / A191T / N239H / I259V / A276T / A328I / A330S / L353I / I401L / L437LL catalyzes isophorone to obtain (4S) 4-hydroxyisophorone diastereomeric excess rate can reach 95%, yield can reach 96%; the cytochrome P450 BM3 Monooxygenase mutant catalyzes isophorone synthesis (4S) 4-hydroxyisophorone process is simple, environmental protection, and industrialization prospect is good.

The invention discloses 10-hydroxydecanoic acid as well as a preparation method and application thereof, and belongs to the technical field of cosmetics, Candida lipolytica is taken as a fermentation thallus, the Candida lipolytica contains alkane monooxygenase (CYP450), alcohol dehydrogenase (ADH), fatty alcohol oxidase (FAO) and fatty aldehyde dehydrogenase (FALDH), amplification and activation are performed on the Candida lipolytica in a seed culture medium, and the Candida lipolytica is obtained. The method comprises the following steps: inoculating a seed solution into a liquid culture medium, enabling a strain to adapt to a culture environment in advance, reducing strain death caused by environmental mutation after inoculation, inoculating the seed solution into the liquid culture medium, culturing until OD600 is 45-55, realizing high-density enrichment of the strain, being beneficial to increasing the content of CYP450, ADH, FAO and FALDH, adding decane and Tween 80, and enabling the Tween 80 to be capable of increasing the permeability of a cell membrane and increasing the reaction rate, the CYP450 is used for catalyzing decane to carry out hydroxylation, and ADH, FAO and FALDH are used for carrying out oxidation, so that the high-purity 10-hydroxydecanoic acid is obtained.

The invention discloses 4-hydroxy-3-methyl benzoic acid monooxygenase, a strain and a preparation method and application thereof, and relates to the technical field of bioengineering, the nucleotide sequence of the 4-hydroxy-3-methyl benzoic acid monooxygenase is shown as SEQ ID NO: 1, and the amino acid sequence of the 4-hydroxy-3-methyl benzoic acid monooxygenase is shown as SEQ ID NO: 2 and / or SEQ ID NO: 3. The gene of the 4-hydroxy-3-methyl benzoic acid monooxygenase disclosed by the invention can be used for encoding to obtain the 4-hydroxy-3-methyl benzoic acid monooxygenase, and the obtained 4-hydroxy-3-methyl benzoic acid monooxygenase can be used for effectively catalyzing continuous oxidation of ortho-methyl of hydroxyl in 4-hydroxy-3-methyl benzoic acid; the selective continuous oxidation of the ortho-position methyl of the 4-hydroxy-3-methylbenzoic acid can be realized, the 4-hydroxyisophthalic acid is generated, and the compound 4-hydroxyisophthalic acid with industrial added value is synthesized while the selective oxidation of the methyl is solved.

This invention relates to increasing the level of peptidyl glycine α-amidyl monooxygenase (PAM) in human circulation as a long-acting drug and for treating subjects, wherein said treatment includes: reducing the likelihood or risk of disease or condition, and / or reducing the occurrence of disease or condition, and / or reducing the severity of disease or condition.

The application discloses a method for promoting transport and improving retinal synthesis, which is obtained by introducing an exogenous ABC transport protein Pdr5 into a host fungus and adding a copy of beta-carotene-15, 15'-monooxygenase BLH; wherein the host fungus is a genetically modified Pichia pastoris strain PP-BCCIV. The application further verifies the retinal production performance of the recombinant strain by screening different surfactants, and further improves the ability of Pichia pastoris to produce retinal. At the same time, all the retinal is extracted into the extracellular, and all the carotenes are left in the intracellular, so as to achieve the co-production of carotenes and retinal. The recombinant Pichia pastoris of the application has a simple construction method, can better promote the synthesis of retinal and other vitamin A, and can make the engineering strain utilize glucose and methanol to efficiently synthesize retinal through a 5 L fermentation tank, which is beneficial to industrial production.

The invention relates to the field of genetic engineering and fermentation engineering, and discloses a genetically engineered bacterium for producing melatonin and application of the genetically engineered bacterium in fermentation production of melatonin. According to the invention, genes of mtrA, PTPS, SPR, PCD and DHPR of related enzymes synthesized by coding 2-amino-6-(1, 2-dihydroxypropyl)-5, 6, 7, 8-tetrahydro-4 (1H)-pterin diketone and genes of L-2-amino-3 (beta-indole) propionic acid monooxygenase, oxymethyltransferase, N-acetyltransferase and decarboxylase are co-expressed on the genetically engineered bacterium, so that the gene engineering bacterium is obtained. The strain can be used for fermentation production of melatonin, and experiments show that the yield of the strain can reach 6480 mg / L.

The invention provides a multienzyme system for preparing cellobiose as well as a preparation method and application of cellobiose, and belongs to the technical field of bioengineering. The multi-enzyme system disclosed by the invention is prepared from endoglucanase, cellobiose hydrolase and lysed polysaccharide monooxygenase, wherein the endoglucanase is EG5C-1m, the cellobiose hydrolase is TeCel7A T393K, and the lysed polysaccharide monooxygenase is LsAA9A. According to the method disclosed by the invention, a multi-enzyme system for accurately degrading cellulose into cellobiose is constructed by screening high-efficiency endoglucanase, cellobiose hydrolase and lysed polysaccharide monooxygenase. On the basis, the optimal reaction condition of a multi-enzyme system is determined, a method is provided for efficient generation of cellobiose from cellulose, and a basis is provided for subsequent biomass conversion of high-value products.

This invention relates to the field of biomedicine, and discloses the application of flavin-containing monooxygenase 2 in the preparation of drugs for the treatment of non-alcoholic fatty liver disease. This invention is the first to discover that flavin-containing monooxygenase 2 has a preventive or therapeutic effect on non-alcoholic fatty liver disease.

The application relates to the technical field of wheat kernel type genes, and provides a wheat kernel type gene TaCYT-5A TaCYT-5A The application of the molecular marker is KASP-TaCYT-5A, the marker is a SNP site (C / T) detected at 495818646 bp in a QTL cluster for controlling the wheat kernel type and kernel length traits of a 5A chromosome 484432128-495883712 bp, that is, a 4-hydroxyphenylacetaldehyde oxime monooxygenase gene TaCYT-5A The coding region is 124 bp away from the start codon. The functional KASP molecular marker of the wheat 4-hydroxyphenylacetaldehyde oxime monooxygenase gene TaCYT-5A provided by the application can be used for identifying whether an TaCYT-5A excellent allele exists in a wheat variety / strain, and applied in assisted selection breeding and breeding in combination with other known kernel type related genes.

The present invention relates to compounds of formula (I) wherein A is a 3-10 membered carbocyclic ring or a 4-12 membered heterocyclic ring containing 1-4 heteroatoms selected from O, N or S; B is any one of the following groups (1), (2) or (3); C is any one of the following groups (1'), (2'), (3') or (4'); G1 is CH2, NH or O; G2 and G3 are independently of each other CH or N; Z is -C(O)-, -SO2-, -C 1‑3 alkyl- or -CH2-C(O)-; L is a bond, -C 1‑7 alkyl- or -C 1‑7 alkenyl-. The compounds of formula (I) are inhibitors of cytochrome P450 monooxygenase 11A1 (CYP11A1). The compounds are useful as medicaments for the treatment of steroid receptor, e.g. androgen receptor or estrogen receptor dependent diseases and disorders such as cancer including prostate cancer and estrogen cancer.

The present application provides a kind of cytochrome P450 monooxygenase gene and the protein coded by it, recombinant plasmid and application derived from ramie, the coding region sequence of the cytochrome P450 monooxygenase gene derived from ramie is as shown in SEQ ID NO:1, the amino acid sequence of the protein coded by it is as shown in SEQ ID NO:2.The present application takes ramie as research object, obtains ramie cytochrome P450 monooxygenase gene (BnMAX1) by three generations sequencing and gene annotation comparison.Longer coding sequence of the target gene is obtained by PacBio Sequel sequencing, which is simple, fast and easy to operate.The function of the gene is verified by cloning identification, bioinformatics, expression pattern and genetic transformation analysis, which shows that the gene has the effect of relieving plant cadmium toxicity.The acquisition and application of the gene provide basic theoretical support for molecular improvement of cadmium tolerance of ramie, and provide new technical means for how to improve the ecological restoration ability of ramie under heavy metal cadmium stress.

本发明涉及微生物菌肥技术领域，特别是涉及一种菌酶复合微生物菌剂及其制备方法和应用。本发明针对田间秸秆还田腐解慢、影响下茬作物生长的问题，提供了一种菌酶复合微生物菌剂。所述菌酶复合微生物菌剂由草酸青霉（Penicillium oxalicum）菌株F12的孢子悬液与裂解性多糖单加氧酶（LPMO）按特定配比复配而成。田间施用时，将秸秆粉碎抛撒后，通过无人机喷洒菌剂，翻压入土，并调节土壤相对湿度。本发明解决了秸秆腐解慢的技术难题，有助于促进种子出苗和减少病虫害发生，可在秸秆还田场景和菌剂生产企业中推广应用。

The invention relates to cold-resistant pseudoarthrobacter LH-LT-1 resistant to heavy metal stress and low temperature as well as a microbial agent and application thereof, and belongs to the technical field of microorganisms. The cold-resistant pseudoarthrobacter LH-LT-1 is classified and named as Pseudarthrobacter psychrotolerans, and the preservation number of the cold-resistant pseudoarthrobacter LH-LT-1 is CGMCC (China General Microbiological Culture Collection Center) No. 32708. The cold-tolerant pseudoarthrobacter LH-LT-1 can amplify gene sequences of ammonia monooxygenase, hydroxylamine oxidoreductase and the like based on gene primers of amoA, hao and the like, and can amplify gene sequences of cold shock protein, cold shock protein, ATP binding protein, excision nuclease and the like based on gene primers of Csp4, cspA II, atpH, uvrC and the like. The strain can tolerate multiple heavy metal ions such as Pb < 2 + >, Ni < 2 + > and Cd < 2 + >, can efficiently reduce ammonia nitrogen under the stress of cadmium ions at 5 DEG C, and provides an efficient and low-cost biological solution for reducing ammonia nitrogen in sewage and wastewater at low temperature of 5 DEG C under the stress of a series of heavy metals represented by cadmium.

A genetically modified prokaryotic cell to express enzymes involved in the production of taurine. Said prokaryote comprises a vanin selected from: vanin- 1 (vnn-1), vanin-2 (vnn-2), or vanin- 3 (vnn-3), a cysteamine dioxygenase (ado), and a flavin-containing monooxygenase 1 (fmol), in addition to either the addition, alteration, or deletion of at least one gene involved in taurine synthesis or transport.

The application discloses a kind of Baeyer-Villiger monooxygenase and its mutant in synthesis optical pure 3-substituted chiral butyrolactone Application, the application with the Baeyer-Villiger monooxygenase ArBVMO of Acinetobacter radioresistens (CGMCC No.25186) source of resistance to radiation Acinetobacter (Acinetobacter radioresistens) and its mutant as biocatalyst, can catalyze the asymmetric oxidation of series latent chiral 3-substituted cyclobutanone, preparation corresponding optical pure chiral butyrolactone.Compared with prior art, the application has the advantages of high enzyme reaction substrate concentration, mild reaction condition, environment-friendly, high space-time yield, high product optical purity, and has good application prospect.

The invention provides application of a flavin monooxygenase 3 inhibitor in preparation of a medicine for preventing and / or treating acute pancreatitis, and belongs to the technical field of medicines. The flavin monooxygenase 3 inhibitor is methimazole or a pharmaceutically acceptable salt, a prodrug or a derivative of methimazole. Experimental results show that after the methimazole is orally taken, the nidus area of animal pancreatitis is obviously reduced, the pathological score is obviously improved, the in-vivo inflammation level is obviously inhibited, and the blood amylase and lipase levels are obviously reduced; the levels of pancreatitis factors and chemotactic factors are reduced, and the oxidative stress index is reduced. In addition, by combining methimazole with the traditional Chinese medicine monomer for inhibiting the trimethylamine oxide level, the curative effect is better. Compared with the prior art, the application has the advantages that the core regulation effect of the trimethylamine oxide in the pathological process of the acute pancreatitis is disclosed for the first time, the limitation of the traditional anti-inflammatory or enzyme replacement therapy is broken through, and the acute pancreatitis is treated by inhibiting the trimethylamine oxide level by inhibiting the flavin monooxygenase 3.

The present invention relates to: a photocatalyst comprising methane monooxygenase (MMO) hydroxylase (MMOH), a halogenated xanthene dye as a light harvester, and MMOB as a catalyst conductivity enhancer; and a use thereof for methanol production, and exhibits catalytic activity superior to that in a natural biocatalytic reaction using MMO-based enzymes.

A synthesis method for a chiral epoxide catalyzed by styrene monooxygenase. The synthesis method comprises: carrying out an enzyme catalysis reaction on a raw material system comprising oxidase, an olefin compound, reductase, dehydrogenase, a hydrogen donor, FAD, and NAD+ so as to obtain a chiral epoxide. R2 and R3 are each independently selected from substituents such as H, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 heteroalkyl, and a substituted or unsubstituted C2-C6 ester group; and R1 is selected from substituents such as halogen, hydroxy, carboxyl, acetoxy, and substituted or unsubstituted C1-C6 alkyl. The raw material system is used for carrying out the enzyme catalysis reaction, and the oxidase in the raw material system is used so as to obtain the chiral epoxide. The synthesis method for the chiral epoxide catalyzed by the oxidase has the advantages of a short synthesis route, a wide range of substrate types, high selectivity, mild reaction conditions, less three wastes, and low costs.

This invention relates to the field of microbial technology, disclosing a *Strombus adhesiveus* strain YF2 that degrades polyethylene mulch film, microbial preparations, methods, and applications, addressing the problems of insufficient efficacy and unclear mechanisms in existing PE-degrading strains. This strain is deposited at the Guangdong Provincial Microbial Culture Collection Center, with accession number GDMCC No:67086, and a deposit date of October 13, 2025. Through systematic parallel comparisons, strain YF2 significantly outperformed the control strain in PE degradation efficiency, biofilm formation ability, and induction of PE polymer oxidation. Genomic analysis showed that YF2 contains a genetic network encoding key degrading enzyme systems such as nitroreductase, cytochrome P450, and alkane monooxygenase, and particularly possesses unique nitrification degradation potential. Microbial preparations prepared based on this strain can be used for the bioremediation of PE mulch film residues in farmland soils, compost, and other environments.

This invention relates to the field of pest control technology, and discloses a double-stranded RNA and its application in the control of citrus aphids. The double-stranded RNA comprises a double-stranded RNA consisting of the nucleotide sequence shown in SEQ ID NO:2 and its reverse complementary nucleotide sequence; the nucleic acid molecule encoding the double-stranded RNA is shown in SEQ ID NO:1 or SEQ ID NO:3. The double-stranded RNA provided by this invention can simultaneously target the chitin synthase gene, cytochrome P450 monooxygenase gene, and epidermal protein gene of the brown citrus aphid, and simultaneously silence the expression of these three key genes through an RNA interference mechanism, leading to inhibited growth and development or death of the brown citrus aphid. Therefore, the double-stranded RNA provided by this invention can efficiently and specifically control the brown citrus aphid; it can reduce the use of chemical pesticides, is green and environmentally friendly, and safe and harmless.

The present application relates to the technical field of biosynthesis, and specifically discloses a method for selectively hydroxylating 16-position of dehydroabietyl acid based on CYP153 family cytochrome P450 enzyme, which comprises the following steps: plasmid construction, heterologous expression of CYP153A99-RhFRED in Escherichia coli, heterologous expression of opt13 in Escherichia coli, and crude enzyme catalytic conversion reaction. By optimizing the codon bias of the protein sequence of cytochrome monooxygenase in the CYP153 family, the p450 enzyme CYP153A99 with the biological catalytic function of catalyzing the hydroxylation of C16 position of dehydroabietyl acid is obtained, high-site selective oxidation of dehydroabietyl acid is realized, the substrate spectrum and application field of the CYP153 family P450 enzyme are expanded, and a new technical path is provided for the green synthesis of dehydroabietyl acid derivatives.

The application discloses a lytic polysaccharide monooxygenase mutant, a preparation method and application thereof. In view of the problems of a low expression level and poor stability of a lytic polysaccharide monooxygenase in a microbial expression system, a multi-site mutant with an amino acid sequence shown in SEQ ID NO. 2 is obtained by mutating the lytic polysaccharide monooxygenase RsLPMO9, and the expression level of the multi-site mutant is obviously higher than that of a wild-type protein RsLPMO9. The analysis of thermal stability shows that the thermal stability of the multi-site mutant is obviously improved compared with that of the wild-type protein RsLPMO9. The lytic polysaccharide monooxygenase mutant provided by the application has application prospects in the degradation of biomass or plant polysaccharides.

A pharmaceutical composition contains an attenuated bacterial strain of Brucella melitensis engineered to produce 5-hydroxyindole. The attenuated Brucella melitensis can contain a deletion of one or more of vjbR, asp 14, or mucR virulence genes, along with a first gene encoding for tryptophanase and a second gene encoding for toluene-4 monooxygenase. Methods of treatment of disease include administering a pharmaceutical composition containing an attenuated bacterial strain of Brucella melitensis engineered to produce 5-hydroxyindole to the patient. Methods of treatment of disease include administering a pharmaceutical composition containing an attenuated bacterial strain of Brucella melitensis expressing an immunomodulatory factor to the patient. Methods of treatment of disease include further administering 5-hydroxyindole to the patient.

Provided are a styrene monooxygenase mutant and the use thereof. The styrene monooxygenase mutant comprises: (a) a protein having an amino acid sequence as shown in SEQ ID NO: 1; (b) a protein having an amino acid mutation on at least one of the following sites in the above amino acid sequence of (a): I206, S107, P54, N307, S178, L310, L275, L204, W86, E202, H392 or E221, and having the function of styrene monooxygenase; or (c) a protein having 80% or more homology to the amino acid sequence defined in either (a) or (b) and having the function of styrene monooxygenase. The styrene monooxygenase mutant can solve the problem of low activity of styrene monooxygenase in the prior art, has good properties such as high activity and / or wide range of substrate selection, has high economic value and broad application prospects, and is applicable in the field of enzymatic catalysis.

Recombinant yeasts bioengineered to overexpress genes for utilization of cellulosic and hemicellulosic fibers and / or produce lipid, and methods of use thereof. The yeasts are modified to express, constitutively express, or overexpress an exo-cellobiohydrolase I, an exo-cellobiohydrolase II, an endoglucanase, an endoxylanase, or any combination thereof. The yeasts may also be modified to express, constitutively express, or overexpress a lytic polysaccharide monooxygenase, an arabionofuranosidase, a xylanases, an acetylxylan esterase, or any combination thereof. The methods include cultivating the recombinant yeasts to convert low value organic stillage byproducts such as cellulose and hemicellulose into lipids suitable for biodiesel production and other higher value uses.